Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab Rechallenge in Colorectal Cancer Liver Metastasis
NCT04509635Phase 3Unknown
- Sponsor
- Fudan University
- Start
- Sep 2020
- Primary completion
- Aug 2022
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 3 trial of cetuximab in colorectal cancer (CRC), sponsored by Fudan University. Status: unknown.
02
Drugs
cetuximab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT04509635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04509635.